GlassScriptPhysician profile
Tyler Bogaczyk
NPI 1487340428
$420.58
in general payments reported to CMS, 2019-2025
12 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $179 · 2024: $58.45 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $115.46 | 2023 | Ligasure |
| Astrazeneca Pharmaceuticals LP | $56.94 | 2024-2025 | Tagrisso, Andexxa, Enhertu |
| Kci USA, INC. | $33.60 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Caris Mpi, INC. | $32.66 | 2025 | Mi Cancer Seek |
| Mozarc Medical US LLC | $29.44 | 2023 | Palindrome |
| Takeda Pharmaceuticals U.S.A., INC. | $28.34 | 2025 | Gattex |
| Abbott Laboratories | $24.29 | 2025 | Esprit |
| La Jolla Pharmaceutical Company | $23.74 | 2024 | Xerava |
| Vertex Pharmaceuticals Incorporated | $21.65 | 2025 | |
| Incyte Corporation | $20.81 | 2025 | Zynyz, Monjuvi |
| Daiichi Sankyo INC. | $19.27 | 2025 | Enhertu |
| Terumo Medical Corporation | $14.38 | 2024 | Angio-Seal, Azur Cx Detachable, Navicross |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Bogaczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.